KRT17 has been reported to be overexpressed in many types of cancer including UBC, breast cancer, colon cancer, non-small lung cancer, cervical cancer, oral cancer, esophagus cancer, pancreatic cancer, etc. KRT17 overexpression is associated with poor prognosis and cancer progression in non-small lung cancer24, colon cancer25 and other types of cancer26. Here, KRT17 is linked to breast carcinoma.